View Inscriptions  
Multi-District Litigation Information (MDL)

Multidistrict Litigation is litigation comprised of multiple civil cases involving one or more common questions of fact which have been transferred from different federal districts by the Judicial Panel on Multidistrict Litigation to a single federal district for coordinated or consolidated pretrial proceedings under 28 U.S.C. Section 1407.

MDL Cases in the District of Massachusetts:

MDL 1456: Pharmaceutical Industry Average Wholesale Price Litigation (Consolidated with MDL 1453,1454 and 1455)

MDL 1629: Neurontin Marketing and Sales Practices

MDL 2067: In Re: Celexa and Lexapro Marketing and Sales Practices Litigation

MDL 2193: In Re: Bank of America Home Affordable Modification Program (HAMP) Contract Litigation

MDL 2208: In Re: Prudential Insurance Company of America SGLI/VGLI Contract Litigation

MDL 2231: In Re: Lead Contaminated Fruit Juice Products Marketing and Sales Practices Litigation

MDL 2242: In Re: Prograf Antitrust Litigation

MDL 2290: In Re: JPMorgan Chase Mortgage Modification Litigation

MDL 2375: In Re: Body Science LLC Patent Litigation

MDL 2409: Nexium (Esomeprazole) Antitrust Litigation

MDL 2419: New England Compounding Pharmacy, Inc., Products Liability Litigation

MDL 2428: In Re: Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation

MDL 2432: In Re: NeuroGrafix (360) Patent Litigation

 

More information on Multidistrict Litigation can be obtained from the MDL Panel Website: http://www.jpml.uscourts.gov


text size  
Home      Boston      Springfield      Worcester      Mission Statement      Careers      Pro Se Litigants      Records Search      Site Map      BrowseAloud